ITGRNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Integer Holdings Corp
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Aug 4, 2026
$126.75+0.05 (+0.04%)
Close on Oct 19, 2026
- Market cap
- $4.33B
- P/E (TTM)
- 34.6
- Dividend yield
- –
Integer Holdings Corp revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reportable Segment | $1.85B | $1.72B | $1.56B | – | – | – | – | – | – | – | 100.0% | +8.0% |
| Non-Medical | – | – | $43.33M | $46.55M | $38.45M | $35.46M | $58.42M | $52.98M | $56.97M | $41.68M | – | – |
| Medical | – | – | $1.55B | $1.33B | $1.18B | $1.04B | $1.20B | $1.16B | $1.08B | $1.03B | – | – |
| Operating income | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Reportable Segment | $221.26M | $208.24M | $163.32M | $112.68M | – | – | – | – | – | – | +6.3% |
| Non-Medical | – | – | $3.18M | $7.57M | $8.02M | $4.85M | $16.29M | $14.70M | $11.34M | $1.51M | – |
| Medical | – | – | $269.51M | $205.88M | $213.60M | $169.40M | $223.87M | $224.89M | $197.21M | $170.10M | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cardio & Vascular | $1.11B | $949.58M | $836.34M | $699.40M | – | – | – | – | – | – | 59.7% | +16.6% |
| Cardiac Rhythm Management & Neuromodulation | $668.80M | $660.61M | $612.89M | $534.37M | – | – | – | – | – | – | 36.1% | +1.2% |
| Other Markets | $77.75M | $106.41M | $106.42M | $97.51M | – | – | – | – | – | – | 4.2% | -26.9% |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $979.81M | $938.68M | $872.93M | $732.60M | $671.50M | $596.80M | $698.47M | $687.26M | $662.13M | $625.67M | 52.9% | +4.4% |
| Rest of world | $469.89M | $431.76M | $383.73M | $408.46M | $372.44M | $321.74M | $341.34M | $319.21M | $278.40M | $233.99M | 25.3% | +8.8% |
| Costa Rica | $173.52M | $124.69M | $108.42M | $76.14M | $66.98M | $58.85M | $63.63M | $62.04M | $55.36M | $53.50M | 9.4% | +39.2% |
| Puerto Rico | $131.26M | $137.06M | $121.49M | $114.08M | $110.16M | $96.05M | $154.64M | $146.50M | $140.18M | $162.34M | 7.1% | -4.2% |
| Ireland | $99.16M | $84.41M | $69.09M | – | – | – | – | – | – | – | 5.3% | +17.5% |
| Belgium | – | – | – | – | – | – | – | – | – | $69.15M | – | – |
From the segment and revenue-disaggregation notes of Integer's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.